2f:I[703058,["/_next/static/immutable/chunks/2esyeua7r8hxb.js","/_next/static/immutable/chunks/43wzqu_q6b8co.js","/_next/static/immutable/chunks/02igegklyi312.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/3d54cr_x61503.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/41sb2pnxui1_7.js","/_next/static/immutable/chunks/0z5fu495o1bws.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 30:T53e,Of 549 included participants with chronic skin diseases, 287 (52.3%) were female, 262 (47.7%) were male, and the median (IQR) age was 36 (30-45) years. A total of 249 patients (45.1%) had atopic dermatitis, 246 (44.8%) had acne, and 113 (20.6%) had psoriasis. The anxiety, depression, social satisfaction, and social isolation short-form measures demonstrated adequate structural validity (ie, all with comparative fit index and/or Tucker-Lewis index values greater than 0.95; standardized root mean residual values less than 0.08) and internal consistency (Cronbach α values greater than 0.90). All measures showed sufficient construct validity on known-groups and convergent validity testing (eg, magnitude of Pearson correlations between measures evaluating similar underlying constructs with values of 0.30 or greater). When comparing responsiveness based on standardized response means (SRMs), the pain (SRM, 0.41) and itch intensity (SRM range, 0.32-0.44) measures showed similar responsiveness as the Skindex-29 symptoms domain (SRM, 0.47), and the social satisfaction (SRM, -0.20) and isolation (SRM, 0.27) measures showed similar responsiveness to the Skindex-29 functioning domain (SRM, 0.25). Responsiveness of the anxiety (SRM, 0.11) and depression (SRM, 0.16) measures were lower than the Skindex-29 emotions domain (SRM, 0.43).31:Tb6c,Patient-Reported Outcomes Measurement Information System (PROMIS) is a generalized set of patient-reported outcome measures (PROMs) that can be readily integrated into the dermatologic clinic setting, but the measurement properties of these PROMs among patients with a range of chronic skin diseases have yet to be established. To evaluate the structural validity, internal consistency, construct validity, and responsiveness of PROMIS short-form measures for anxiety, depression, social satisfaction, and social isolation as well as the construct validity and responsiveness of single-item pain and itch intensity measures. In this cohort study, adults 18 years and older with a self-reported chronic skin disease (eg, atopic dermatitis, acne, psoriasis) were recruited in February 2025 from across the US via an online survey platform. Enrolled participants completed a baseline survey of PROMIS and several other relevant measures and then a follow-up survey 3 months later. Measures collected include the PROMIS measures, Dermatology Life Quality Index, Skindex-29, a baseline patient global assessment, and a change in skin disease anchor question at follow-up. Structural validity, internal consistency, construct validity, and responsiveness were evaluated for the short-form measures. Construct validity and responsiveness were assessed for the single-item measures. Of 549 included participants with chronic skin diseases, 287 (52.3%) were female, 262 (47.7%) were male, and the median (IQR) age was 36 (30-45) years. A total of 249 patients (45.1%) had atopic dermatitis, 246 (44.8%) had acne, and 113 (20.6%) had psoriasis. The anxiety, depression, social satisfaction, and social isolation short-form measures demonstrated adequate structural validity (ie, all with comparative fit index and/or Tucker-Lewis index values greater than 0.95; standardized root mean residual values less than 0.08) and internal consistency (Cronbach α values greater than 0.90). All measures showed sufficient construct validity on known-groups and convergent validity testing (eg, magnitude of Pearson correlations between measures evaluating similar underlying constructs with values of 0.30 or greater). When comparing responsiveness based on standardized response means (SRMs), the pain (SRM, 0.41) and itch intensity (SRM range, 0.32-0.44) measures showed similar responsiveness as the Skindex-29 symptoms domain (SRM, 0.47), and the social satisfaction (SRM, -0.20) and isolation (SRM, 0.27) measures showed similar responsiveness to the Skindex-29 functioning domain (SRM, 0.25). Responsiveness of the anxiety (SRM, 0.11) and depression (SRM, 0.16) measures were lower than the Skindex-29 emotions domain (SRM, 0.43). In this study, PROMIS measures were valid for assessing the physical, emotional, and social effects of chronic skin diseases, and measures for physical and social impact tracked improvements with treatment.32:Tf96, Importance Patient-Reported Outcomes Measurement Information System (PROMIS) is a generalized set of patient-reported outcome measures (PROMs) that can be readily integrated into the dermatologic clinic setting, but the measurement properties of these PROMs among patients with a range of chronic skin diseases have yet to be established. Objective To evaluate the structural validity, internal consistency, construct validity, and responsiveness of PROMIS short-form measures for anxiety, depression, social satisfaction, and social isolation as well as the construct validity and responsiveness of single-item pain and itch intensity measures. Design, Setting, and Participants In this cohort study, adults 18 years and older with a self-reported chronic skin disease (eg, atopic dermatitis, acne, psoriasis) were recruited in February 2025 from across the US via an online survey platform. Enrolled participants completed a baseline survey of PROMIS and several other relevant measures and then a follow-up survey 3 months later. Main Outcomes and Measures Measures collected include the PROMIS measures, Dermatology Life Quality Index, Skindex-29, a baseline patient global assessment, and a change in skin disease anchor question at follow-up. Structural validity, internal consistency, construct validity, and responsiveness were evaluated for the short-form measures. Construct validity and responsiveness were assessed for the single-item measures. Results Of 549 included participants with chronic skin diseases, 287 (52.3%) were female, 262 (47.7%) were male, and the median (IQR) age was 36 (30-45) years. A total of 249 patients (45.1%) had atopic dermatitis, 246 (44.8%) had acne, and 113 (20.6%) had psoriasis. The anxiety, depression, social satisfaction, and social isolation short-form measures demonstrated adequate structural validity (ie, all with comparative fit index and/or Tucker-Lewis index values greater than 0.95; standardized root mean residual values less than 0.08) and internal consistency (Cronbach α values greater than 0.90). All measures showed sufficient construct validity on known-groups and convergent validity testing (eg, magnitude of Pearson correlations between measures evaluating similar underlying constructs with values of 0.30 or greater). When comparing responsiveness based on standardized response means (SRMs), the pain (SRM, 0.41) and itch intensity (SRM range, 0.32-0.44) measures showed similar responsiveness as the Skindex-29 symptoms domain (SRM, 0.47), and the social satisfaction (SRM, −0.20) and isolation (SRM, 0.27) measures showed similar responsiveness to the Skindex-29 functioning domain (SRM, 0.25). Responsiveness of the anxiety (SRM, 0.11) and depression (SRM, 0.16) measures were lower than the Skindex-29 emotions domain (SRM, 0.43). Conclusions and Relevance In this study, PROMIS measures were valid for assessing the physical, emotional, and social effects of chronic skin diseases, and measures for physical and social impact tracked improvements with treatment. 25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"adult (18-64) in Dermatology: Research & Clinical Takeaways\",\"description\":\"Explore peer-reviewed Dermatology papers on adult (18-64) (age group). Clinician-written summaries and practical action steps. Updated daily.\",\"url\":\"https://www.reachrx.ai/hub/Dermatology/age_group/adult%20(18-64)\",\"breadcrumb\":{\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://www.reachrx.ai\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Hub\",\"item\":\"https://www.reachrx.ai/hub\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Dermatology Hub\",\"item\":\"https://www.reachrx.ai/hub/Dermatology\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"age group: adult (18-64)\",\"item\":\"https://www.reachrx.ai/hub/Dermatology/age_group/adult%20(18-64)\"}]}}"}}]],["$","$L2f",null,{"title":"adult (18-64) in Dermatology Research","description":"Age-specific Dermatology evidence for adult (18-64) — concise summaries and practical next steps.","papers":[{"doi":"10.1001/jamadermatol.2025.5163","pmid":"41432938","title":"Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases","journal_title":"JAMA Dermatology","journal_issn":"2168-6068","published_at":"2025-12-23T00:00:00.000Z","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12728729/","source_score":26,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2025-12-25","doi":"10.1001/jamadermatol.2025.5163","days":"30","issn":"2168-6068","rank":"4","field":"Clinical Medicine","score":"26","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1001/jamadermatol.2025.5163","title":"Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases.","journal":"JAMA dermatology","methods":"","results":"$30","abstract":"$31","keywords":[],"pubmed_id":"41432938","conclusions":"","publication_date":"2025-12-23T00:00:00"},"crossref":{"DOI":"10.1001/jamadermatol.2025.5163","URL":"https://doi.org/10.1001/jamadermatol.2025.5163","ISSN":["2168-6068"],"link":[{"URL":"https://jamanetwork.com/journals/jamadermatology/articlepdf/2842851/jamadermatology_nock_2025_oi_250063_1765296580.48453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":null,"type":"journal-article","issue":null,"score":1,"title":["Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases"],"author":[{"given":"Michael R.","family":"Nock","sequence":"first","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut"}]},{"given":"Sherry","family":"Ershadi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"}]},{"given":"Abizairie","family":"Sánchez-Feliciano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"}]},{"given":"Anissa Valentina","family":"Amstutz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}]},{"given":"Andrea L.","family":"Pusic","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Brigham and Women’s Hospital, Boston, Massachusetts"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Associate Editor, JAMA Dermatology"}]}],"issued":{"date-parts":[[2025,12,23]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":null,"created":{"date-time":"2025-12-23T16:00:46Z","timestamp":1766505646000,"date-parts":[[2025,12,23]]},"indexed":{"date-time":"2025-12-23T16:57:25Z","timestamp":1766509045216,"date-parts":[[2025,12,23]]},"subject":[],"abstract":"$32","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamadermatology/fullarticle/2842851"}},"subtitle":[],"deposited":{"date-time":"2025-12-23T16:00:48Z","timestamp":1766505648000,"date-parts":[[2025,12,23]]},"issn-type":[{"type":"print","value":"2168-6068"}],"published":{"date-parts":[[2025,12,23]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1016/j.jid.2022.01.008","key":"doi250063r1","year":"2022","issue":"6","author":"Secrest","volume":"142","first-page":"1529","unstructured":null,"article-title":"Incorporating patient-reported outcomes as a vital sign for dermatologic clinical care and clinical investigations.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257-023-00758-8","key":"doi250063r2","year":"2023","issue":"4","author":"Snyder","volume":"24","first-page":"499","unstructured":null,"article-title":"Patient-reported outcome measures and their clinical applications in dermatology.","journal-title":"Am J Clin Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2024.1281","key":"doi250063r3","year":"2024","issue":"8","author":"Hopkins","volume":"160","first-page":"801","unstructured":null,"article-title":"Validating patient-reported outcome measures in dermatology.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2021.3341","key":"doi250063r4","year":"2021","issue":"10","author":"Barbieri","volume":"157","first-page":"1236","unstructured":null,"article-title":"Patient-reported outcome measures as complementary information to clinician-reported outcome measures in patients with psoriasis.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11136-021-03030-w","key":"doi250063r5","year":"2022","issue":"6","author":"Taliercio","volume":"31","first-page":"1719","unstructured":null,"article-title":"Clinicians’ perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study.","journal-title":"Qual Life Res","doi-asserted-by":"publisher"},{"DOI":"10.1002/jmrs.421","key":"doi250063r6","year":"2021","issue":"2","author":"Nguyen","volume":"68","first-page":"186","unstructured":null,"article-title":"A review of the barriers to using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine cancer care.","journal-title":"J Med Radiat Sci","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jid.2019.12.017","key":"doi250063r7","year":"2020","issue":"5","author":"Terwee","volume":"140","first-page":"1089","unstructured":null,"article-title":"The value of item banks, CAT, and PROMIS for dermatology.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2023.6245","key":"doi250063r8","year":"2024","issue":"4","author":"Shields","volume":"160","first-page":"441","unstructured":null,"article-title":"Identifying core outcome domains in chronic skin disease using the best-worst scaling method.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s00403-020-02074-1","key":"doi250063r10","year":"2021","issue":"1","author":"Esaa","volume":"313","first-page":"17","unstructured":null,"article-title":"The utility of PROMIS domain measures in dermatologic care.","journal-title":"Arch Dermatol Res","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.18978","key":"doi250063r11","year":"2020","issue":"5","author":"Silverberg","volume":"183","first-page":"891","unstructured":null,"article-title":"Measurement properties of the Patient-Reported Outcomes Information System (PROMIS®) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jid.2019.08.452","key":"doi250063r12","year":"2020","issue":"5","author":"Silverberg","volume":"140","first-page":"986","unstructured":null,"article-title":"Development, validation, and interpretation of the PROMIS Itch Questionnaire: a patient-reported outcome measure for the quality of life impact of itch.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2019.11.057","key":"doi250063r13","year":"2020","issue":"5","author":"Silverberg","volume":"82","first-page":"1174","unstructured":null,"article-title":"Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire item banks in adults with atopic dermatitis.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jid.2021.10.015","key":"doi250063r14","year":"2022","issue":"5","author":"Paller","volume":"142","first-page":"1309","unstructured":null,"article-title":"Generation and validation of the Patient-Reported Outcome Measurement Information System Itch Questionnaire-Child (PIQ-C) to measure the impact of itch on life quality.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.18920","key":"doi250063r15","year":"2020","issue":"5","author":"Lei","volume":"183","first-page":"875","unstructured":null,"article-title":"Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in adults with atopic dermatitis.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2020.05.138","key":"doi250063r16","year":"2023","issue":"2","author":"Fishbein","volume":"88","first-page":"348","unstructured":null,"article-title":"Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.clinthera.2014.04.006","key":"doi250063r17","year":"2014","issue":"5","author":"Cappelleri","volume":"36","first-page":"648","unstructured":null,"article-title":"Overview of classical test theory and item response theory for the quantitative assessment of items in developing patient-reported outcomes measures.","journal-title":"Clin Ther","doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257-019-00496-w","key":"doi250063r24","year":"2020","issue":"3","author":"Perez-Chada","volume":"21","first-page":"323","unstructured":null,"article-title":"Investigator and patient global assessment measures for psoriasis clinical trials: a systematic review on measurement properties from the International Dermatology Outcome Measures (IDEOM) Initiative.","journal-title":"Am J Clin Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11136-024-03761-6","key":"doi250063r25","year":"2024","issue":"11","author":"Mokkink","volume":"33","first-page":"2929","unstructured":null,"article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures version 2.0.","journal-title":"Qual Life Res","doi-asserted-by":"publisher"},{"DOI":"10.1111/j.1365-2133.2008.08832.x","key":"doi250063r26","year":"2008","issue":"5","author":"Basra","volume":"159","first-page":"997","unstructured":null,"article-title":"The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jclinepi.2006.03.012","key":"doi250063r27","year":"2007","issue":"1","author":"Terwee","volume":"60","first-page":"34","unstructured":null,"article-title":"Quality criteria were proposed for measurement properties of health status questionnaires.","journal-title":"J Clin Epidemiol","doi-asserted-by":"publisher"},{"DOI":"10.1177/0049124114543236","key":"doi250063r28","year":"2015","issue":"3","author":"Kenny","volume":"44","first-page":"486","unstructured":null,"article-title":"The performance of RMSEA in models with small degrees of freedom.","journal-title":"Sociol Methods Res","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi250063r29","year":"2016","issue":"3","author":"Taasoobshirazi","volume":"11","first-page":"31","unstructured":null,"article-title":"The performance of the SRMR, RMSEA, CFI, and TLI: an examination of sample size, path size, and degrees of freedom.","journal-title":"J Appl Quant Methods","doi-asserted-by":null},{"DOI":"10.1080/00273171.2020.1868965","key":"doi250063r30","year":"2022","issue":"2-3","author":"Shi","volume":"57","first-page":"179","unstructured":null,"article-title":"Evaluating SEM model fit with small degrees of freedom.","journal-title":"Multivariate Behav Res","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11136-021-02925-y","key":"doi250063r31","year":"2021","issue":"10","author":"Terwee","volume":"30","first-page":"2729","unstructured":null,"article-title":"Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures.","journal-title":"Qual Life Res","doi-asserted-by":"publisher"},{"DOI":"10.1111/jdv.20321","key":"doi250063r33","year":"2025","issue":"3","author":"Vyas","volume":"39","first-page":"631","unstructured":null,"article-title":"The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: a systematic review.","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2019.09.008","key":"doi250063r34","year":"2023","issue":"1","author":"Perez-Chada","volume":"88","first-page":"86","unstructured":null,"article-title":"Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1093/bjd/ljaf127","key":"doi250063r35","year":"2025","issue":"2","author":"Nock","volume":"193","first-page":"267","unstructured":null,"article-title":"Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.12.017","key":"doi250063r36","year":"2024","issue":"5","author":"Reynolds","volume":"90","first-page":"1006.e1","unstructured":null,"article-title":"Guidelines of care for the management of acne vulgaris.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.08.102","key":"doi250063r37","year":"2024","issue":"2","author":"Davis","volume":"90","first-page":"e43","unstructured":null,"article-title":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.04.061","key":"doi250063r38","year":"2022","issue":"3","author":"Chatrath","volume":"87","first-page":"582","unstructured":null,"article-title":"Longitudinal course and predictors of depressive symptoms in atopic dermatitis.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.2165/00128071-200304120-00003","key":"doi250063r39","year":"2003","issue":"12","author":"Gupta","volume":"4","first-page":"833","unstructured":null,"article-title":"Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management.","journal-title":"Am J Clin Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.18514","key":"doi250063r40","year":"2020","issue":"3","author":"Gaufin","volume":"182","first-page":"786","unstructured":null,"article-title":"Practical screening for depression in dermatology: using technology to improve care.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.14031","key":"doi250063r41","year":"2015","issue":"6","author":"Silverberg","volume":"173","first-page":"1400","unstructured":null,"article-title":"Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation study.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1159/000136655","key":"doi250063r42","year":"2008","issue":"2","author":"Menon","volume":"217","first-page":"164","unstructured":null,"article-title":"Validity of subject self-report for acne.","journal-title":"Dermatology","doi-asserted-by":"publisher"},{"DOI":"10.1038/JID.2015.386","key":"doi250063r43","year":"2016","issue":"1","author":"Modalsli","volume":"136","first-page":"323","unstructured":null,"article-title":"Validity of self-reported psoriasis in a general population: the HUNT Study, Norway.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.anai.2018.07.040","key":"doi250063r44","year":"2018","issue":"6","author":"Silverberg","volume":"121","first-page":"729","unstructured":null,"article-title":"Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.","journal-title":"Ann Allergy Asthma Immunol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2024.5679","key":"doi250063r45","year":"2025","issue":"3","author":"Griffiths","volume":"161","first-page":"332","unstructured":null,"article-title":"Validation of the Acne Core Outcomes Research Network patient global assessment for acne.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/jdv.16562","key":"doi250063r46","year":"2021","issue":"1","author":"van Geel","volume":"35","first-page":"216","unstructured":null,"article-title":"Validation of a patient global assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES).","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"publisher"},{"DOI":"10.1111/j.0022-202X.2005.23775.x","key":"doi250063r47","year":"2005","issue":"4","author":"Nijsten","volume":"125","first-page":"665","unstructured":null,"article-title":"The psychometric properties of the Psoriasis Disability Index in United States patients.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jclinepi.2007.03.012","key":"doi250063r48","year":"2008","issue":"2","author":"Revicki","volume":"61","first-page":"102","unstructured":null,"article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.","journal-title":"J Clin Epidemiol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s10209-018-0617-5","key":"doi250063r49","year":"2019","issue":"4","author":"Hargittai","volume":"18","first-page":"881","unstructured":null,"article-title":"From internet access to internet skills: digital inequality among older adults.","journal-title":"Univers Access Inf Soc","doi-asserted-by":"publisher"},{"DOI":"10.1111/jgs.12747","key":"doi250063r50","year":"2014","issue":"4","author":"Remillard","volume":"62","first-page":"696","unstructured":null,"article-title":"Systematic review of the use of online questionnaires of older adults.","journal-title":"J Am Geriatr Soc","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jval.2021.08.011","key":"doi250063r51","year":"2022","issue":"2","author":"Peipert","volume":"25","first-page":"161","unstructured":null,"article-title":"Do you recall?: results from a within-person recall study of the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0–Physical Function 8c.","journal-title":"Value Health","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi250063r9","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"HealthMeasures. PROMIS measures in Epic. Accessed June 28, 2024. https://www.healthmeasures.net/implement-healthmeasures/administration-platforms/epic","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r18","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Anxiety instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Anxiety_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r19","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Depression instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Depression_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r20","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Satisfaction With Social Roles and Activities instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/promis/manuals/PROMIS_Satisfaction_with_Participation_in_Social_Roles_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r21","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Social Isolation instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Social_Isolation_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r22","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Pain Intensity instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Pain_Intensity_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r23","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Itch instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Itch_Scoring_Manual.pdf.","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r32","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"HealthMeasures. Meaningful change for PROMIS. Accessed October 19, 2025. https://www.healthmeasures.net/score-and-interpret/interpret-scores/promis/meaningful-change","article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Dermatology"],"reference-count":51,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2025,12,23]]},"references-count":51,"short-container-title":["JAMA Dermatol"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1001/jamadermatol.2025.5163","is_oa":true,"title":"Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases","updated":"2025-12-27T00:44:22+00:00","published_date":"2025-12-23","best_oa_location":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12728729/","pmh_id":"oai:pubmedcentral.nih.gov:12728729","url_for_pdf":null,"url_for_landing_page":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12728729/"}}},"created_at":"2026-01-19T09:31:36.873Z","updated_at":"2026-01-21T12:05:26.220Z","tags":[{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"age_group","value":"adult (18-64)","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"condition","value":"Atopic Dermatitis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"condition","value":"Psoriasis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"sample_size","value":"n=549","value_numeric":549},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"study_design","value":"Cohort Study","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"warning","value":"Design classified as a cohort study based on the abstract description.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"warning","value":"Diagnoses were self-reported via an online survey platform, which may limit generalizability to clinician-confirmed populations.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"warning","value":"Only a 3-month follow-up was evaluated; longer-term responsiveness is not addressed.","value_numeric":null}],"summaries":{"what_studied":"Adults (≥18 years) in the US with self-reported chronic skin diseases completed PROMIS short forms (anxiety, depression, social satisfaction, social isolation) and single-item itch and pain at baseline and 3 months to test structural validity, internal consistency, construct validity, and responsiveness against dermatology measures.","key_result":"Across 549 participants, PROMIS short forms showed adequate structural validity (CFI/TLI >0.95; SRMR <0.08) and high internal consistency (Cronbach α >0.90), with sufficient construct validity (Pearson r ≥0.30 for similar constructs). Responsiveness by SRM: pain 0.41 and itch 0.32–0.44 (similar to Skindex-29 symptoms 0.47); social satisfaction −0.20 and isolation 0.27 (similar to Skindex-29 functioning 0.25); anxiety 0.11 and depression 0.16 (lower than Skindex-29 emotions 0.43).","practice_takeaway":"PROMIS pain, itch, and social measures tracked 3-month changes similarly to Skindex-29 domains, supporting their use in dermatology clinics; PROMIS anxiety and depression were less responsive than Skindex-29 emotions."}}],"initialOffset":1,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"category","value":"Dermatology"},{"tag_type":"age_group","value":"adult (18-64)"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Dermatology","href":"/hub/Dermatology"},{"name":"age group: adult (18-64)","metadata":{"type":"age_group","value":"adult (18-64)"}}],"hrefConfig":{"basePath":"/hub/Dermatology/papers","webViewQueryParams":{"hub_ctx":"category_tag","hub_category":"Dermatology","hub_tag_type":"age_group","hub_tag_value":"adult (18-64)"}}}]]

Papers